Boston Private Bank & Trust’s Pfizer PFE Stock Holding History

Boston Private Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$31.9M	Sell	965,508 -25,043	-3%	-$796K	1.47%	7
2014 Q4	$29.3M	Sell	990,551 -5,034	-0.5%	-$144K	1.36%	9
2014 Q3	$27.9M	Sell	995,585 -10,552	-1%	-$296K	1.36%	12
2014 Q2	$28.3M	Buy	1,006,137 +812	+0.1%	+$23.1K	1.37%	11
2014 Q1	$30.6M	Sell	1,005,325 -24,103	-2%	-$719K	1.55%	6
2013 Q4	$29.9M	Buy	1,029,428 +41,069	+4%	+$1.2M	1.49%	4
2013 Q3	$26.9M	Sell	988,359 -12,261	-1%	-$334K	1.49%	6
2013 Q2	$26.6M	Buy	+1,000,620	New	+$27.6M	1.55%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Private Bank & Trust's PFE Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its Pfizer (PFE) stake by 2.5% in Q1 2015, selling an estimated $796K and leaving 965,508 shares worth $31.9M. The position accounts for 1.47% of the portfolio, ranked #7.

Boston Private Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. 1,876 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

Boston Private Bank & Trust held 965,508 shares of Pfizer worth $31.9M as of Q1 2015.
Boston Private Bank & Trust sold 25,043 Pfizer shares in Q1 2015, an estimated $796K.
Pfizer made up 1.47% of Boston Private Bank & Trust's portfolio in Q1 2015, its #7 holding.
Boston Private Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
1,876 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.